Select Page


Reports By The Committee To Unleash Prosperity


 

PDF DOWNLOADS

Right click and select “save as” to download directly to your computer, click to open in your browser.

An America First Critical Mineral and Mining Strategy

By. Dr. Ned Namula- Arguably, no nation on earth has been endowed with a greater abundance of critical and rare earth minerals than the United States.

The National Mining Association estimates that the United States sits atop $6 trillion in mineral resources. We could be easily adding $50 to 100 billion to our GDP every year through a smart, pro-growth mining policy.

If all 17 rare earth elements were counted separately—as they should be—the United States is importing 37 minerals at 100 percent, for a total of 67 key minerals imported at more than 50 percent reliance.

Auto Tariffs Would Disrupt Trump’s Pro-Growth Agenda

By Steven Moore and Phil Kerpen- Donald Trump ran for president promising a tougher stance on trade deals. He argued that many of these agreements were unfair to American companies and U.S. workers and promised to bring back jobs and factories that had fled these shores for nations like Mexico, China, and Japan. In particular he expressed concern for American steel and auto workers whose jobs were being lost due to “lousy trade deals.” This was often a popular position with blue collar union workers whose wages had been stagnant for nearly two decades.

 

 

 

NAFTA REFORM MUST BETTER PROTECT INTELLECTUAL PROPERTY

By Steven Moore- As the Trump administration seeks to renegotiate the North American Free Trade Agreement with Canada and Mexico, a key issue for U.S. trade negotiators is better and more enforceable protections of intellectual property (IP) rights. This must include more legally binding protections of patents, copyrights, trademarks, trade secrets, and other engines of invention and creation, which face a growing array of threats in foreign markets, including even our closest North American trade partners.

 
 
By Steven Moore and Steve Forbes- Foreign Price Controls Jeopardize Global Health and Raise Drug Costs for Americans // Stephen Moore and Steve Forbes
Perhaps the most common complaint about the U.S. health care system is that Americans spend more on medical care than the
citizens of any other nation without commensurate health benets. While our health care delivery and insurance systems havemany ineciencies, one element that can drive up costs is global in scope: compared with citizens of other developed countries,Americans bear a disproportionate share of the hundreds of billions of dollars spent each year developing new drugs, vaccines,medical devices, and other life-saving health technologies.